Late-breaking clinical evidence presented at #ACC2024 shows fundamental design differences in #TAVR devices can impact valve performance. Explore the evidence. https://bit.ly/3U9gHv9 Risk info: https://bit.ly/4cOdzfp
关于我们
A global healthcare technology leader — boldly attacking the most challenging health problems facing humanity with innovations that transform lives.
- 网站
-
https://medtronic.com
Medtronic Cardiac and Vascular 的外部链接
- 所属行业
- 医疗设备
- 规模
- 超过 10,001 人
- 总部
- Minneapolis ，MN
- 创立
- 1949
动态
-
The Medtronic-sponsored CRYSTAL-AF study was published 10 years ago and paved the way for atrial fibrillation (AF) detection with insertable cardiac monitors (ICMs) in cryptogenic stroke patients. Results showed that continuous cardiac monitoring with ICMs is the superior monitoring strategy for detecting AF in this patient population compared to standard of care.1 Learn more and see important safety info: https://bit.ly/4frYIbt
-
The most comprehensive review of published atherectomy data to date was just released at #VIVA24. Peripheral Vascular Health Chief Medical Officer John Laird, MD, shares the highlights below. See all the data: https://bit.ly/4eur1ES
New literature review finds more data on atherectomy than ever thought
-
#VIVA24 is underway. Vascular experts are gathering to share insights and learn from each other, including Peripheral Vascular Health Chief Medical Officer John Laird, MD. Hear what he's most looking forward to.
-
Is your #CathLab ready for the latest hypertension treatment option, the Symplicity? blood pressure procedure? Complement your patients' meds and lifestyle changes and be a part of the turning point in hypertension care. View our website for benefits/risks and learn more about the therapy now. Product usage represented may not be approved or cleared in all markets.
-
-
Learn more about the Valiant? Captivia? thoracic stent graft system on Medtronic Academy. Continued education at your own pace! https://bit.ly/48666Xn For risk information: https://bit.ly/485pHqB
-
We are excited to share new data presented at #APHRS2024 and published in Heart Rhythm Journal. To learn more about the Reliability Modeling Study results evaluating the durability of the novel Omnia Secure? defibrillation lead, read the manuscript: https://bit.ly/3XIWsVT
-
-
??Don't miss the durability study with PulseSelect? PFA system at APHRS! We’re excited to share the first invasive remapping results on the durability of PVI using PulseSelect. Stay tuned! Learn more: https://bit.ly/3Y2f9Fu See risk info: https://bit.ly/3ZILIJB
-
-
Coming soon at APHRS24 - four late breaking clinical trials discussing the full suite of Medtronic cardiac ablation technologies. Learn more: https://bit.ly/3XXJJQw See risk info: https://bit.ly/3ZCMWWI
-
It's #ValveWeek24! Help your patients with aortic stenosis know they aren't alone. Encourage them to speak up with this simple and engaging symptom checklist. Silence is NOT golden. https://bit.ly/3XNxLIW